首页> 外国专利> MEDICINAL AGENT FOR TREATMENT OF ANIMAL DISEASE OF BACTERIAL ETIOLOGY, METHOD OF TREATMENT OF GASTROENTERIC DISEASE OF BACTERIAL ETIOLOGY IN ANIMALS AND METHOD OF TREATMENT OF GYNECOLOGICAL DISEASE OF BACTERIAL ETIOLOGY IN ANIMALS

MEDICINAL AGENT FOR TREATMENT OF ANIMAL DISEASE OF BACTERIAL ETIOLOGY, METHOD OF TREATMENT OF GASTROENTERIC DISEASE OF BACTERIAL ETIOLOGY IN ANIMALS AND METHOD OF TREATMENT OF GYNECOLOGICAL DISEASE OF BACTERIAL ETIOLOGY IN ANIMALS

机译:细菌病动物病的治疗药物,动物细菌病的胃肠道疾病的治疗方法以及动物细菌病的妇科疾病的治疗方法

摘要

FIELD: veterinary science. SUBSTANCE: medicinal agent has the following components, wt.-%: rifampicin, 0.9-1.1; polymixin M sulfate, 0.9-1.1; native aubazidan, 17.5-22.5; nipagin, 0.1-0.15; citric acid, 1.0-1.2; sodium hydroxide, 0.3-0.35; and water, the balance. Optimal ratio of active components is the following, wt.-%: rifampicin, 1.0; polymixin M sulfate, 1.0. Medicinal agent can be used for treatment of gastroenteric disease in animals being preferably by oral route at dose 1 ml/kg body mass, 2 times per a day for 2-4 days. Medicinal agent can be used for treatment of gynecological disease in cows being preferably by intrauterine route at dose 200-300 ml, once per 2-3 days. EFFECT: enhanced effectiveness of agent. 5 cl, 3 tbl
机译:领域:兽医学。物质:药物具有以下重量百分比:利福平0.9-1.1;多元混合蛋白M硫酸盐,0.9-1.1;本地aubazidan,17.5-22.5;尼泊金0.1-0.15;柠檬酸1.0-1.2;氢氧化钠0.3-0.35;和水,平衡。活性成分的最佳比例为wt .-%:利福平为1.0;利福平为1.0。多元混合蛋白M硫酸盐,1.0。药物可优选以1ml / kg体重的剂量通过口服途径用于治疗动物的肠胃疾病,每天2-4次,每天两次。药物可用于牛的妇科疾病的治疗,最好是通过子宫内途径,每2-3天一次,剂量为200-300 ml。效果:增强了药剂的效力。 5厘升,3汤匙

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号